Brief: Matinas Biopharma Reports First Quarter 2022 Financial Results And Operational Highlights
12/05/2022 11:32
May 12 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* QTRLY NET LOSS OF $0.03 PER SHARE
Source text for Eikon: ID:nGNX7G2Ddf
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors